Union Health Minister J P Nadda informed Lok Sabha that ICMR received ₹172 crore royalty from Bharat Biotech for Covaxin. After objections, BBIL added ICMR and scientists as co-owners and co-inventors. Covaxin was also provided to seven countries under the Vaccine Maitri programme. #Covaxin #VaccineMaitri #ICMR #BharatBiotech
